Frontlight ResearchEarly access
Brain metastases trials in United Kingdom
8 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleImmunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer
- Where
- London, Manchester
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- ETOP IBCSG Partners Foundation
See details and how to joinNCT05522660 - Phase 1/2Taking peoplePhase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Where
- London, Manchester
- Age
- 18 years and over
- People
- 554 worldwide
- Run by
- Institut de Recherches Internationales Servier
See details and how to joinNCT05786924 · EU 2025-523474-16-00 - Phase 1/2Taking peopleStudy of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Where
- Leicester, Liverpool, London, Manchester
- Age
- 18 years and over
- People
- 73 worldwide
- Run by
- Stemline Therapeutics, Inc.
See details and how to joinNCT05386108 · EU 2024-512878-98-00 - No phaseTaking peopleBEAT-Breast: Trial of DE-iPTV in Patients With Primary Breast Cancer With Brain Metastases Who Are Not Suitable for Stereotactic Radiotherapy.
- Where
- London, Oxford
- Age
- 16 years to 100 years
- People
- 42
- Run by
- Imperial College London
See details and how to joinNCT06611306 - Phase 1Taking peopleA Phase 1/1b Study of IAM1363 in HER2 Cancers
- Where
- Chelsea, Oxford, Sutton
- Age
- 18 years and over
- People
- 383 worldwide
- Run by
- Iambic Therapeutics, Inc
See details and how to joinNCT06253871 - No phaseNot yet taking people in United KingdomTargeted Pediatric High-Grade Glioma Therapy
- Where
- London
- Age
- 12 months to 39 years
- People
- 350 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05839379 - Phase 2Not yet taking people in United KingdomStudy of Olutasidenib and Temozolomide in HGG
- Where
- London
- Age
- 12 years to 39 years
- People
- 60 worldwide
- Run by
- Rigel Pharmaceuticals
See details and how to joinNCT06161974 - Phase 2Not yet taking people in United KingdomStudy of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Where
- London
- Age
- 12 months to 39 years
- People
- 120 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05843253